As we all know that the characteristic of K562/A02 cells is amplification of mdr-1 and frequently the production of P-170 glycoprotein in cell surface.
Consequently, the drug is pumped out from cell [2] . Our results suggest that berberine increase chemosensitivity of K562/A02 cells to adriamycin through accumulation of drug in cells.
It may be the mechanism that though some other effects need to be studied further berberine reverse drug resistance by inhibiting P-170 glycoprotein or by sealing up the efflux pump in membrane of K562/A02 cells [3] . 
